Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

dual tasking

- PMLiVE

FDA’s Gottlieb lambasts industry’s biosimilar-blocking tactics

Speech coincides with Biosimilars Action Plan

- PMLiVE

Allergan’s abicipar matches AMD blockbuster Lucentis in phase III

Bayer's Eylea remains the drug to beat, however

Novartis day

Daily brief: Novartis spends big on ezcema, Kite invests, another gene therapy IPO

A round up from pharma, biotech and healthcare

AstraZeneca AZ

AstraZeneca joins Merck in Brexit stockpiling effort

Says it is increasing stores of medicines by around 20%

- PMLiVE

Vyriad inks immunotherapy alliance with Merck/Pfizer

Genetically engineered virus produces immune response in tumours

- PMLiVE

Huntsworth buys Giant Creative Strategy

New acquisition will expand Huntsworth’s reach

- PMLiVE

Daily Brief: success for Pfizer and Lilly arthritis drug, Darzalex soars, IMI launches Accelerator

A round-up from pharma, biotech and healthcare

- PMLiVE

Brexit rebels win vote on European Medicines Agency alignment

EMA membership will be a key negotiating aim; Sir John Bell sees independent MHRA post-Brexit

- PMLiVE

NHS England to Vertex: come clean on Orkambi offer

Vertex has offered Orkambi at an almost 90% discount to the NHS, according to BioCentury

Data Visualisation

Last week’s Thirsty Thursday was all about data visualisation and was hosted by Katherine Mantell, Managing Director of Leading Edge – part of the Lucid family of companies.Katherine started the session with...

Lucid Group Communications Limited

The True Potential of Mobile Health Tech

In a recent edition of PME, Dennis O’Brien, Lucid CEO and co-founder, discusses the potential of mobile health in improving patient outcomes – a goal that is at the heart...

Lucid Group Communications Limited

- PMLiVE

Novartis follows Pfizer and freezes US prices this year

And still expects revenues to come in at the high end of expectations for 2018

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links